ArticleRevista da Associacao Medica Brasileira (1992)2023

Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India.

Amit Varshney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.